Abstract: The present invention provides an accurate method to identify and quantify the Borrelia burgdorferi (Bb) antigen, the cause of Lyme Disease, in a sample of whole blood, body tissues and fluids of a subject, a human or animal subject. The qualitative method provides a quick, easy and accurate method of detection of the Bb antigen. The quantitative method allows for monitoring of treatment in conjunction with severity of clinical signs and symptoms.
Type:
Grant
Filed:
June 19, 2002
Date of Patent:
January 4, 2005
Assignee:
Bowen Research and Training
Inventors:
Jo Anne Whitaker, Eleanor G. Fort, Donna M. Hamilton